Subsequent chemotherapy reverses acquired tyrosine kinase inhibitor resistance and restores response to tyrosine kinase inhibitor in advanced non-small-cell lung cancer

類似資料

• Advances in studies of tyrosine kinase inhibitors and their acquired resistance
  著者:: Jiao, Qinlian, 等
  出版事項: (2018)
• Chemotherapy With Erlotinib or Chemotherapy Alone in Advanced Non-Small Cell Lung Cancer With Acquired Resistance to EGFR Tyrosine Kinase Inhibitors
  著者:: Goldberg, Sarah B., 等
  出版事項: (2013)
• Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
  著者:: Xu, Haiyuan, 等
  出版事項: (2019)
• Mutational spectrum of acquired resistance to reversible versus irreversible EGFR tyrosine kinase inhibitors
  著者:: Wagener-Ryczek, Svenja, 等
  出版事項: (2020)
• Mechanisms of acquired resistance to tyrosine kinase inhibitors
  著者:: Yi-fan Chen, 等
  出版事項: (2011-12-01)